Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

A join point survival model for brain tumor patients.

Vovoras D, Vrionis FD, Tsokos CP, Prokhel K.

Int J Biomed Sci. 2011 Dec;7(4):249-54.

2.

Modelling population-based cancer survival trends using join point models for grouped survival data.

Yu B, Huang L, Tiwari RC, Feuer EJ, Johnson KA.

J R Stat Soc Ser A Stat Soc. 2009 Apr;172(2):405-425.

4.
5.

Effect of pretreatment clinical factors on overall survival in glioblastoma multiforme: a Surveillance Epidemiology and End Results (SEER) population analysis.

Thumma SR, Fairbanks RK, Lamoreaux WT, Mackay AR, Demakas JJ, Cooke BS, Elaimy AL, Hanson PW, Lee CM.

World J Surg Oncol. 2012 May 3;10:75. doi: 10.1186/1477-7819-10-75.

6.

Five-year survival rates and time trends of laryngeal cancer in the US population.

Cosetti M, Yu GP, Schantz SP.

Arch Otolaryngol Head Neck Surg. 2008 Apr;134(4):370-9. doi: 10.1001/archotol.134.4.370.

PMID:
18427002
7.

Semiparametric Bayesian approaches to joinpoint regression for population-based cancer survival data.

Ghosh P, Huang L, Yu B, Tiwari RC.

Comput Stat Data Anal. 2009 Oct 1;53(12):4073-40.

8.

Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.

Mukherjee D, Chaichana KL, Gokaslan ZL, Aaronson O, Cheng JS, McGirt MJ.

J Neurosurg Spine. 2011 Feb;14(2):143-50. doi: 10.3171/2010.10.SPINE10189. Epub 2010 Dec 24.

PMID:
21184634
10.

Adult brain cancer in the U.S. black population: a Surveillance, Epidemiology, and End Results (SEER) analysis of incidence, survival, and trends.

Gabriel A, Batey J, Capogreco J, Kimball D, Walters A, Tubbs RS, Loukas M.

Med Sci Monit. 2014 Aug 25;20:1510-7. doi: 10.12659/MSM.890762.

11.

The Surveillance, Epidemiology, and End Results Cancer Survival Calculator SEER*CSC: validation in a managed care setting.

Feuer EJ, Rabin BA, Zou Z, Wang Z, Xiong X, Ellis JL, Steiner JF, Cynkin L, Nekhlyudov L, Bayliss E, Hankey BF.

J Natl Cancer Inst Monogr. 2014 Nov;2014(49):265-74. doi: 10.1093/jncimonographs/lgu021.

12.

Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.

Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LA, Schrag D, Jamison PM, Jemal A, Wu XC, Friedman C, Harlan L, Warren J, Anderson RN, Pickle LW.

J Natl Cancer Inst. 2005 Oct 5;97(19):1407-27.

PMID:
16204691
13.
14.

Cancers of the upper aerodigestive tract in Ontario, Canada, and the United States.

Skarsgard DP, Groome PA, Mackillop WJ, Zhou S, Rothwell D, Dixon PF, O'Sullivan B, Hall SF, Holowaty EJ.

Cancer. 2000 Apr 1;88(7):1728-38.

PMID:
10738233
15.

Cancer prevalence estimates based on tumour registry data in the Surveillance, Epidemiology, and End Results (SEER) Program.

Merrill RM, Capocaccia R, Feuer EJ, Mariotto A.

Int J Epidemiol. 2000 Apr;29(2):197-207.

PMID:
10817114
16.

The NCI All Ireland Cancer Conference.

Johnston PG, Daly PA, Liu E.

Oncologist. 1999;4(4):275-277.

19.

Conditional survival in gastric cancer: a SEER database analysis.

Wang SJ, Emery R, Fuller CD, Kim JS, Sittig DF, Thomas CR.

Gastric Cancer. 2007;10(3):153-8. Epub 2007 Sep 26.

PMID:
17922092

Supplemental Content

Support Center